SymptomsDepends on diagnosis or indication
History
- NPO status
- Shellfish, iodine, IV contrast, or protamine reactions
- Ability to lie flat, snoring, sleep apnea
- Acquired or implanted metallic devices, extensive tattoos, permanent eye make-up
Signs/Physical Exam
- Depends on diagnosis or indication and can include a baseline-focused neurologic exam, Glasgow Coma Scale, disease-specific scoring system (Hunt Hess for subarachnoid hemorrhage and NIHSS for stroke)
- General medical and airway exam
Medications - Interventional procedures: Antiplatelets, anticoagulants; calcium channel blockers for cerebral protection or reducing vasospasm; triple H therapy for prophylaxis or treatment of vasospasm (induced hypertension, hemodilution, hypervolemia)
- Intraoperative MRI: Steroids, diuretics, anticonvulsants
- Pain medications: for headache, surgical pain in iMRI procedures
- Medications specific to the patient's co-morbidities
Diagnostic Tests & InterpretationLabs/Studies
- BUN/Cr is often attained prior to IV contrast.
- Depends on comorbidities
CONCOMITANT ORGAN DYSFUNCTION Depends on procedure indication
Outline
- May require transport over long distances to the postanesthesia care unit (PACU); monitors, supplemental oxygenation, airway equipment, and emergency drugs should be considered as appropriate.
- Standard PACU evaluation, care, and discharge criteria
- No flexion at the groin for a few hours after femoral groin access is removed; consider reverse Trendelenburg positioning if "head up" is needed.
Bed Acuity Variable
Analgesia - Interventional radiologic procedures are usually not painful, and local anesthetics are injected at the access site.
- Short-acting narcotics are often preferable to longer-acting narcotics.
Complications- Vascular perforation of the access site
- Obliteration of the wrong vessel
- Contrast dye reactions can range from mild symptoms such as scattered urticaria and pruritus to laryngeal edema, life-threatening arrhythmias, hypotension, bronchospasm, pulmonary edema, seizures, syncope, and even death. Nonionic contrast media has been shown to decrease the incidence significantly.
- Contrast nephropathy: Usually occurs at 13 days after contrast injection. Patients at increased risk include pre-existing renal disease, volume depletion, high or repeat doses of contrast, and administration of other nephrotoxic drugs. Use of oral or IV theophylline, acetylcysteine, fenoldapam, statins, or bosentan (an endothelin antagonist) have not shown consistent efficacy against renal insult.
PrognosisVariable depending on the preoperative morbidity, the underlying pathology, site and extent of procedure
Outline